Drug Type CAR-T |
Synonyms anti-CD22 CAR-T therapy, Anti-CD22 chimeric antigen receptor T-cell therapies |
Target |
Action modulators |
Mechanism CD22 modulators(CD22 modulators), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Phase 1 | China | 05 Aug 2019 | |
B-Cell Lymphoma | Phase 1 | China | 05 Aug 2019 |